BW 1003C87

Known as: BW-1003C87 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-1999
01219921999

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
We compared the effects of three conventional (phenytoin, carbamazepine and phenobarbital) and three novel (BW 1003C87… (More)
Is this relevant?
1994
1994
We have investigated the neuroprotective effect of the pyrimidine derivative BW 1003C87 (5-[2,3,5-trichlorophenyl] pyrimidine-2,4… (More)
Is this relevant?
1993
1993
Sound-induced seizures in genetically epilepsy-prone rats were used to compare the anticonvulsant effect of phenytoin and… (More)
Is this relevant?
1992
1992
BW 1003C87, 5-(2,3,5-trichlorophenyl)-2,4-diaminopyrimidine ethane sulphonic acid, has been tested for its in vitro and in vivo… (More)
Is this relevant?
1992
1992
Excessive release of glutamate has been implicated in the pathogenesis of excitotoxic neurologic disorders, such as stroke. BW… (More)
Is this relevant?